Publication:
Exendin-4 as a versatile therapeutic agent for the amelioration of diabetic changes

Thumbnail Image

School / College / Institute

Organizational Unit
GRADUATE SCHOOL OF HEALTH SCIENCES
Upper Org Unit
Organizational Unit

Program

KU-Authors

KU Authors

Co-Authors

Ahmadi, Mahdi
Aslani, Somayeh
Saberianpour, Shirin
Rahbarghazi, Reza

Publication Date

Language

Type

Embargo Status

NO

Journal Title

Journal ISSN

Volume Title

Alternative Title

Abstract

Type 2 diabetes mellitus (T2DM) is a chronic metabolic abnormality leading to microvascular and macrovascular complications. Non-insulin Incretin mimic synthetic peptide exendin-4 was introduced as an anti-diabetic drug which helped diabetic patients with triggering insulin secretion; further researches have revealed an effective role of exendin-4 in treatment of T2DM related diseases. Exendin-4 is approximately similar to Glucagon like peptide, thus it can bind to the glucagon-like peptide-1 receptor (GLP-1R) and activated different signaling pathways that are involved in various bioactivides such as apoptosis, insulin secretion and inactivation of microglial. In this review, we investigated the interesting role of exendin-4 in various kinds of T2DM related disorders through the activation of different signaling pathways.

Source

Publisher

Tabriz University of Medical Sciences

Subject

Pharmacology and pharmacy

Citation

Has Part

Source

Advanced Pharmaceutical Bulletin

Book Series Title

Edition

DOI

10.34172/apb.2022.025

item.page.datauri

Link

Rights

Copyrights Note

Endorsement

Review

Supplemented By

Referenced By

0

Views

3

Downloads

View PlumX Details